Torii Pharmaceutical Co (TRXPF) Stock Statistics & Valuation Metrics

Torii Pharmaceutical Co has a market cap or net worth of $1.21B. The enterprise value is $174.45B.

Torii Pharmaceutical Co has 28,800,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Torii Pharmaceutical Co’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 4.16%.

The current PE Ratio of Torii Pharmaceutical Co is 26.29. Torii Pharmaceutical Co’s PEG ratio is 3.15.

In the last 12 months, Torii Pharmaceutical Co had revenue of 60.43B and earned 5.04B in profits. Earnings per share was 179.37.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Torii Pharmaceutical Co pays an annual dividend of $0.415, resulting in a dividend yield of 2.27%

Torii Pharmaceutical Co upcoming earnings date is ―, ―.

Torii Pharmaceutical Co as a current ratio of 5.21, with Debt / Equity ratio of 0.46%

In the past 12 months, Torii Pharmaceutical Co has paid 1.68B in taxes.

Torii Pharmaceutical Co EV to EBITDA ratio is 17.99, with an EV/FCF ratio of 37.18.

Torii Pharmaceutical Co has $43.30B in cash and marketable securities with ¥429.00M in debt, giving a net cash position of -$42.87B billion.

Gross margin is 40.67%, with operating margin of 11.25%, and net profit margin of 8.34%.

The average price target for Torii Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―